I was good for a few mill today I'm liking that market...

First 38 Last

Share
Profile

Follow
possum87

466 Posts.

81

18/02/20

18:45

Post #: 43004407
Share

Originally posted by Glitterati: ↑

Mickey, it's great to have you on board, always love your input.

It's terrific to have your learned friend confirm my suspicions that the $15M MC is just ridiculous; the fact that this IPO was at 20c gives a hint as to what its fair value is - and the IPO dates back to 2017, a LOT of progress has been made since then.

I remember back when the ann. came out around the FDA designation of the Magsense as a breakthrough device that the SP shot up to around 6 - 7c and thinking I missed the boat. I recently had another look at IBX and couldn't believe that the SP was sitting at 1.9c and that was most definitely my cue to buy in.

People bang on about the TAs and filling the gap and so and so on, fundamentals are king for me as well; we have a potential ground breaking technology that's going to be worth in the billions and that's my focus.

You're right about the MD Anderson Center; it's the largest cancer research centre in the world and just happens to be the No.4 shareholder in IBX with 10.5 million, is that validation enough that we're on to something here??

Expand

I was good for a few mill today I'm liking that market depth again clearly traders flushed out again and only about 4-5 mill getting traded between .029- high 3s. From my reading of the FDA the turn around is relatively short term looks like we've found a good place to be

IBX Price at posting: 3.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

2 Great analysis

Reply

Top Stories

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PL3

Patagonia looks to raise $2.15M for South American exploration and development

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

There are more pages in this discussion • 30 more messages in this thread...

First 38 Last

Add IBX (ASX) to my watchlist

(20min delay)
Last 8.2¢		Change 0.000(0.00%)		Mkt cap ! $2.677M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	10941	8.2¢

Sellers (Offers)

Price($)	Vol.	No.
8.5¢	305	1

View Market Depth

No.	Vol.	Price($)
2	10941	0.082
1	15000	0.081
3	62156	0.080
1	13155	0.076
2	32500	0.075

Price($)	Vol.	No.
0.085	305	1
0.086	16254	1
0.087	1250	1
0.088	8563	1
0.089	295	1

Last trade - 10.04am 09/07/2024 (20 minute delay)

IBX (ASX) Chart

Day chart unavailable

I was good for a few mill today I'm liking that market...

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I was good for a few mill today I&apos;m liking that market...

Top Stories

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I was good for a few mill today I'm liking that market...